Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

Stephen R. Marder*, Larry Alphs, Ion George Anghelescu, Celso Arango, Thomas R E Barnes, Ivo Caers, David G. Daniel, Eduardo Dunayevich, W. Wolfgang Fleischhacker, George Garibaldi, Michael F. Green, Philip D. Harvey, René S. Kahn, John M. Kane, Richard S E Keefe, Bruce Kinon, Stefan Leucht, Jean Pierre Lindenmayer, Anil K. Malhotra, Virginia StaufferDaniel Umbricht, Keith Wesnes, Shitij Kapur, Jonathan Rabinowitz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science